Eli Lilly and Company Logo

Eli Lilly and Company (0Q1G)

LSE

Currency in CHF
1,020.00
+340.00 (+50.00%)

Real-time Data

07:00 AM

Day's Range

1,020.00
1,020.00

52 wk Range

460.00
1,020.00

Profile - 0Q1G - Eli Lilly and Company

Profile

Mic Code

XLON

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

50K


Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines for human health. The company focuses on major therapeutic areas including cardiometabolic health, oncology, immunology, neuroscience, and rare diseases, with a portfolio that spans treatments for diabetes, obesity, cancer, autoimmune conditions, and neurological disorders. Eli Lilly and Company also operates in animal health-related products in some markets, supporting a broader healthcare presence. Its business is centered on prescription medicines and biologic therapies, combining research, clinical development, and large-scale manufacturing to serve patients, healthcare providers, and health systems worldwide. Headquartered in Indianapolis, Indiana, Eli Lilly and Company is widely recognized for its role in advancing innovative treatments and maintaining a strong position in the global pharmaceutical market.

Profile Details

Type

Common Stock

Ceo

Mr. David A. Ricks

Address

Lilly Corporate Center

City

Indianapolis

State

IN

Zip

46285

Country

United States

Phone

317 276 2000

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.